1 minute reading time (68 words)

Multiple Sclerosis Drug Could Reduce Painful Side Effects of Common Cancer Treatment

Source: Rockefeller University Press
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, published in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing myeloma patients to successfully complete their treatment and relieving the pain of myeloma survivors.
Full story...

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More